Press Release Details
Colfax Reports Third Quarter 2011 Results
Third Quarter of 2011 (all comparisons versus the third quarter of 2010)
- Net income of
$3.7 million (8 cents per share — basic and diluted); adjusted net income (as defined below) of$16.3 million (37 cents per share), an increase of 71.6% - Net sales of
$170.3 million , an increase of 28.6%; organic sales increase (as defined below) of 10.4% - Operating income of
$5.4 million ; adjusted operating income (as defined below) of$23.9 million , an increase of 53.2% - Third quarter orders of
$174.8 million , an increase of 40.9%; organic order increase (as defined below) of 28.8% - Backlog of
$373.4 million at period end
Nine Months Ended
- Net income of
$20.6 million (47 cents per share — basic and diluted); adjusted net income (as defined below) of$40.5 million (91 cents per share), an increase of 73.8% - Net sales of
$515.6 million , an increase of 37.4%; organic sales increase (as defined below) of 14.0% - Operating income of
$33.5 million ; adjusted operating income (as defined below) of$62.8 million , an increase of 59.8% - Year-to-date 2011 orders of
$529.4 million , an increase of 32.6%; organic order increase (as defined below) of 13.3%
Adjusted net income, adjusted net income per share, adjusted operating income, organic sales growth and organic order growth are not financial measures calculated in accordance with generally accepted accounting principles in the U.S. ("GAAP"). See below for a description of the measures' usefulness and a reconciliation of these measures to their most directly comparable GAAP financial measures.
"During the third quarter, we also welcomed
Non-GAAP Financial Measures and Other Adjustments
Colfax has provided in this press release financial information that has not been prepared in accordance with GAAP. These non-GAAP financial measures are adjusted net income, adjusted net income per share, adjusted operating income, earnings before interest, taxes and depreciation (EBITDA), adjusted EBITDA, organic sales growth and organic order growth. Adjusted net income, adjusted net income per share, adjusted EBITDA and adjusted operating income exclude asbestos liability and defense costs and asbestos coverage litigation expenses, restructuring and other related charges, and beginning in Q3 2011, charges related to the proposed Charter acquisition to the extent they impact the periods presented. As we are currently anticipating a reduction in our 2011 adjusted-basis effective tax rate from 32% to 30.5%, the effective tax rates used to calculate adjusted net income and adjusted net income per share present income taxes are 30.5% and 28.2% for the year to date and Q3 periods of 2011, respectively, in comparison to 32% for both the year to date and Q3 periods of 2010. Organic sales growth and organic order growth exclude the impact of acquisitions and foreign exchange rate fluctuations. These non-GAAP financial measures assist Colfax in comparing its operating performance on a consistent basis because, among other things, they remove the impact of legacy asbestos issues, costs related to the Charter acquisition and items outside the control of its operating management team.
Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of non-GAAP financial measures presented above to GAAP results has been provided in the financial tables included in this press release.
Conference Call and Webcast
Colfax will host a conference call to provide details about its results on
About
CAUTIONARY NOTE CONCERNING FORWARD LOOKING STATEMENTS:
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning Colfax's plans, objectives, expectations and intentions and other statements that are not historical or current fact, including the expected effects of the proposed Charter acquisition, its anticipated benefits and potential impact on our business. Forward-looking statements are based on Colfax's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause Colfax's results to differ materially from current expectations include, but are not limited to factors detailed in Colfax's
reports filed with the
The term "Colfax" in reference to the activities described in this press release may mean one or more of Colfax's global operating subsidiaries and/or their internal business divisions and does not necessarily indicate activities engaged in by
| |||||
Three Months Ended | Nine Months Ended | ||||
September 30, 2011 | October 1, 2010 | September 30, 2011 | October 1, 2010 | ||
Net sales | $ 170,294 | $ 132,397 | $ 515,601 | $ 375,336 | |
Cost of sales | 109,667 | 85,300 | 337,046 | 243,502 | |
Gross profit | 60,627 | 47,097 | 178,555 | 131,834 | |
Selling, general and administrative expense | 40,972 | 29,927 | 116,920 | 87,829 | |
Research and development expense | 1,439 | 1,583 | 4,540 | 4,731 | |
Restructuring and other related charges | 5,299 | 2,441 | 7,518 | 9,515 | |
Asbestos liability and defense cost | 4,391 | 2,202 | 7,644 | 4,179 | |
Asbestos coverage litigation expense | 3,086 | 2,339 | 8,454 | 10,763 | |
Operating income | 5,440 | 8,605 | 33,479 | 14,817 | |
Interest expense | 1,218 | 1,544 | 4,507 | 5,075 | |
Income before income taxes | 4,222 | 7,061 | 28,972 | 9,742 | |
Provision for income taxes | 532 | 1,210 | 8,337 | 2,177 | |
Net income | $ 3,690 | $ 5,851 | $ 20,635 | $ 7,565 | |
Net income per share—basic and diluted | $ 0.08 | $ 0.13 | $ 0.47 | $ 0.17 | |
| |||||
Three Months Ended | Nine Months Ended | ||||
September 30, 2011 | October 1, 2010 | September 30, 2011 | October 1, 2010 | ||
EBITDA | |||||
Net income | $ 3,690 | $ 5,851 | $ 20,635 | $ 7,565 | |
Interest expense | 1,218 | 1,544 | 4,507 | 5,075 | |
Provision for income taxes | 532 | 1,210 | 8,337 | 2,177 | |
Depreciation and amortization | 5,306 | 3,932 | 17,426 | 11,242 | |
EBITDA | $ 10,746 | $ 12,537 | $ 50,905 | $ 26,059 | |
EBITDA margin | 6.3% | 9.5% | 9.9% | 6.9% | |
Adjusted EBITDA | |||||
Net income | $ 3,690 | $ 5,851 | $ 20,635 | $ 7,565 | |
Interest expense | 1,218 | 1,544 | 4,507 | 5,075 | |
Provision for income taxes | 532 | 1,210 | 8,337 | 2,177 | |
Depreciation and amortization | 5,306 | 3,932 | 17,426 | 11,242 | |
Charter acquisition-related costs | 5,728 | — | 5,728 | — | |
Restructuring and other related charges | 5,299 | 2,441 | 7,518 | 9,515 | |
Asbestos liability and defense costs | 4,391 | 2,202 | 7,644 | 4,179 | |
Asbestos coverage litigation expenses | 3,086 | 2,339 | 8,454 | 10,763 | |
Adjusted EBITDA | $ 29,250 | $ 19,519 | $ 80,249 | $ 50,516 | |
Adjusted EBITDA margin | 17.2% | 14.7% | 15.6% | 13.5% | |
Adjusted Operating Income | |||||
Operating income | $ 5,440 | $ 8,605 | $ 33,479 | $ 14,817 | |
Charter acquisition-related costs | 5,728 | — | 5,728 | — | |
Restructuring and other related charges | 5,299 | 2,441 | 7,518 | 9,515 | |
Asbestos liability and defense costs | 4,391 | 2,202 | 7,644 | 4,179 | |
Asbestos coverage litigation expenses | 3,086 | 2,339 | 8,454 | 10,763 | |
Adjusted operating income | $ 23,944 | $ 15,587 | $ 62,823 | $ 39,274 | |
Adjusted operating income margin | 14.1% | 11.8% | 12.2% | 10.5% | |
Adjusted Net Income and Adjusted Earnings Per Share | |||||
Net income | $ 3,690 | $ 5,851 | $ 20,635 | $ 7,565 | |
Restructuring and other related charges | 5,299 | 2,441 | 7,518 | 9,515 | |
Charter acquisition-related costs | 5,728 | — | 5,728 | — | |
Asbestos liability and defense costs | 4,391 | 2,202 | 7,644 | 4,179 | |
Asbestos coverage litigation expenses | 3,086 | 2,339 | 8,454 | 10,763 | |
Tax adjustment to effective rate(1) | (5,865) | (3,284) | (9,449) | (8,767) | |
Adjusted net income | $ 16,329 | $ 9,549 | $ 40,530 | $ 23,255 | |
Adjusted net income margin | 9.6% | 7.2% | 7.9% | 6.2% | |
Weighted-average shares outstanding—diluted | 44,411,970 | 43,619,252 | 44,299,157 | 43,539,372 | |
Adjusted net income per share | $ 0.37 | $ 0.22 | $ 0.91 | $ 0.53 | |
Net income per share—diluted (in accordance with GAAP) | $ 0.08 | $ 0.13 | $ 0.47 | $ 0.17 | |
(1) As we are currently anticipating a reduction in our 2011 adjusted-basis effective tax rate from 32% to 30.5%, the effective tax rates used to calculate adjusted net income and adjusted net income per share present income taxes are 30.5% and 28.2% for the year to date and Q3 periods of 2011, respectively, in comparison to 32% for both the year to date and Q3 periods of 2010. | |||||
| |||||
Net Sales | Orders | ||||
$ | % | $ | % | ||
(In millions) | |||||
Three months ended | $ 132.4 | $ 124.1 | |||
Components of Change: | |||||
Existing businesses | 13.8 | 10.4 % | 35.7 | 28.8 % | |
Acquisitions | 14.9 | 11.3 % | 6.0 | 4.8 % | |
Foreign currency translation | 9.2 | 6.9 % | 9.0 | 7.3 % | |
37.9 | 28.6 % | 50.7 | 40.9 % | ||
Three months ended | $ 170.3 | ||||
Net Sales | Orders | Backlog at Period End | |||||
$ | % | $ | % | $ | % | ||
(In millions) | |||||||
As of and for the nine months ended | $ 375.3 | $ 351.2 | |||||
Components of Change: | |||||||
Existing businesses | 52.6 | 14.0 % | 53.2 | 13.3 % | (17.3) | (4.9)% | |
Acquisitions | 65.7 | 17.5 % | 55.1 | 13.8 % | 40.6 | 11.5 % | |
Foreign currency translation | 22.0 | 5.9 % | 21.9 | 5.5 % | (1.1) | (0.3)% | |
140.3 | 37.4 % | 130.2 | 32.6 % | 22.2 | 6.3 % | ||
As of and for the nine months ended | $ 515.6 | $ 373.4 | |||||
SOURCE
News Provided by Acquire Media